Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes-Reference-Cited by-同舟云学术

Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes

Published:2023-04 Issue:4 Volume:45 Page:e115-e126
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Foresta Andreana^ORCID,Ojeda-Fernandez Luisa,Macaluso Giulia,Roncaglioni Maria Carla,Tettamanti Mauro,Fortino Ida,Leoni Olivia,Genovese Stefano,Baviera Marta

Funder

Istituto di Ricerche Farmacologiche Mario Negri - IRCCS

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. Coronavirus disease 2019 case surveillance—United States;Stokes;MMWR Morb Mortal Wkly Rep,2020

2. Factors associated with COVID-19-related death using Open SAFELY;Williamson;Nature,2020

3. Anti-inflammatory effects of metformin irrespective of diabetes status;Cameron;Circulation Res,2016

4. Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with type 2 diabetes mellitus;Carter;Diabetic Med,2005

5. Metformin use is associated with a decrease in risk of hospitalization and mortality in COVID-19 diabetic patients: a population-based study in Lombardy;Ojeda-Fernández;Diabetes Obes Metab,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review;Archives of Virology;2024-05-16

2. The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies;Therapeutic Innovation & Regulatory Science;2024-04-29

3. Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?;Current Pharmaceutical Design;2024-04

4. Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19;Endocrine;2024-03-06

5. Authors’ reply to correspondence to “Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium. Ann Endocrinol (Paris). 2023 Aug 31:S0003-4266(23)00685-6. doi: 10.1016/j.ando.2023.08.002”;Annales d'Endocrinologie;2023-12